Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance

JQ Wang, Y Yang, CY Cai, QX Teng, Q Cui, J Lin… - Drug Resistance …, 2021 - Elsevier
ATP-binding cassette (ABC) transporters mediate the ATP-driven translocation of structurally
and mechanistically distinct substrates against steep concentration gradients. Among the …

Standing the test of time: targeting thymidylate biosynthesis in cancer therapy

PM Wilson, PV Danenberg, PG Johnston… - Nature reviews Clinical …, 2014 - nature.com
Over the past 60 years, chemotherapeutic agents that target thymidylate biosynthesis and
the enzyme thymidylate synthase (TS) have remained among the most-successful drugs …

The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer

LH Matherly, MR Wilson, Z Hou - Drug Metabolism and Disposition, 2014 - ASPET
This review summarizes the biology of the major facilitative membrane transporters, the
reduced folate carrier (RFC)(Solute Carrier 19A1) and the proton-coupled folate transporter …

Folylpoly-γ-glutamate synthetase: a key determinant of folate homeostasis and antifolate resistance in cancer

S Raz, M Stark, YG Assaraf - Drug Resistance Updates, 2016 - Elsevier
Mammalians are devoid of autonomous biosynthesis of folates and hence must obtain them
from the diet. Reduced folate cofactors are B9-vitamins which play a key role as donors of …

Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance

L Taddia, D D'Arca, S Ferrari, C Marraccini… - Drug Resistance …, 2015 - Elsevier
Our current understanding of the mechanisms of action of antitumor agents and the precise
mechanisms underlying drug resistance is that these two processes are directly linked …

[HTML][HTML] Systemic therapy of cutaneous T-cell lymphoma (CTCL)

O Alpdogan, S Kartan, W Johnson… - Chinese clinical …, 2019 - cco.amegroups.org
Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous and relatively rare family of
extranodal non-Hodgkin's lymphomas (NHL) that are primarily localized to the skin. Most …

Therapeutic potential of pteridine derivatives: A comprehensive review

V Carmona‐Martínez, AJ Ruiz‐Alcaraz… - Medicinal Research …, 2019 - Wiley Online Library
Pteridines are aromatic compounds formed by fused pyrazine and pyrimidine rings. Many
living organisms synthesize pteridines, where they act as pigments, enzymatic cofactors, or …

Peripheral T-cell lymphomas: focusing on novel agents in relapsed and refractory disease

A Broccoli, L Argnani, PL Zinzani - Cancer Treatment Reviews, 2017 - Elsevier
Patients with relapsed or refractory peripheral T-cell lymphoma display a dismal prognosis
and their therapy represents an unmet medical need, as the best treatment strategy is yet to …

Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma

D Maruyama, H Nagai, Y Maeda, T Nakane… - Cancer …, 2017 - Wiley Online Library
Pralatrexate is a novel antifolate approved in the USA for the treatment of relapsed or
refractory peripheral T‐cell lymphoma. To assess its safety, efficacy, and pharmacokinetics …

Novel 1, 3, 4-thiadiazole linked amide derivatives of pteridone: Synthesis and study of anticancer activities

ER Devi, R Sreenivasulu, KP Rao… - Letters in Organic …, 2020 - ingentaconnect.com
Cancer is a second leading cause of death after heart attack, in developing as well as
undeveloped countries. It is caused by unregulated growth and metastasis of the abnormal …